Activist Investor Saba Capital Sells $17.85M in Shares Amidst Proxy Battle
ECAT is trading near its 52-week low of $13.36 (14% above the low).
Summary
Activist investor Saba Capital Management sold approximately $17.85 million worth of BlackRock ESG Capital Allocation Term Trust shares, reducing its stake to 19.14% amidst an ongoing proxy battle.
Key Events · Ownership and Investor Activity · ECAT
-
Activist Investor Reduces Stake
Saba Capital Management, an activist investor, sold a total of 1,153,933 shares of BlackRock ESG Capital Allocation Term Trust between May 11 and June 1, 2026.
-
Significant Sales Value
The shares were sold for an approximate total value of $17.85 million, representing about 1.17% of the company's outstanding shares.
-
Sales During Proxy Contest
These sales occurred while Saba Capital is actively engaged in a proxy battle to elect eight nominees to the company's board, and after proxy advisory firms recommended against Saba's proposals.
-
Updated Ownership
Following these transactions, Saba Capital Management's beneficial ownership stands at 19,034,941 shares, or 19.14% of the common stock outstanding.
Analysis · ECAT · Unknown
This filing updates Saba Capital Management's stake in BlackRock ESG Capital Allocation Term Trust, revealing sales of approximately $17.85 million worth of shares between May 11 and June 1, 2026. These sales by the activist investor are notable as they occurred during an ongoing proxy contest where Saba is seeking to elect nominees to the board, and after proxy advisory firms recommended against Saba's proposals. This reduction in stake could signal a shift in strategy or conviction by the activist.
At the time of this filing, ECAT was trading at $15.29 on NYSE in the Unknown sector. The 52-week trading range was $13.36 to $17.14. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.